307 related articles for article (PubMed ID: 28622183)
1. Cyclin D1 Is Expressed in Neoplastic Cells of Langerhans Cell Histiocytosis but Not Reactive Langerhans Cell Proliferations.
Shanmugam V; Craig JW; Hornick JL; Morgan EA; Pinkus GS; Pozdnyakova O
Am J Surg Pathol; 2017 Oct; 41(10):1390-1396. PubMed ID: 28622183
[TBL] [Abstract][Full Text] [Related]
2. CyclinD1 Is Useful to Differentiate Langerhans Cell Histiocytosis From Reactive Langerhans Cells.
Chatterjee D; Vishwajeet V; Saikia UN; Radotra B; De D; Bansal D
Am J Dermatopathol; 2019 Mar; 41(3):188-192. PubMed ID: 30124506
[TBL] [Abstract][Full Text] [Related]
3. Cyclin D1: potential utility as marker for Langerhans cell histiocytosis.
Ben Rejeb S; Charfi L; Sahraoui G; Boujelben N; Mrad K; Doghri R
J Immunoassay Immunochem; 2021 Jul; 42(4):370-379. PubMed ID: 33444078
[TBL] [Abstract][Full Text] [Related]
4. Langerin (CD207) staining in normal pediatric tissues, reactive lymph nodes, and childhood histiocytic disorders.
Chikwava K; Jaffe R
Pediatr Dev Pathol; 2004; 7(6):607-14. PubMed ID: 15630529
[TBL] [Abstract][Full Text] [Related]
5. Use of the JL1 epitope, which encompasses the nonglycosylation site of CD43, as a marker of immature/neoplastic Langerhans cells.
Park HJ; Jeon YK; Lee AH; Oh YH; Park SH; Jung KC
Am J Surg Pathol; 2012 Aug; 36(8):1150-7. PubMed ID: 22790855
[TBL] [Abstract][Full Text] [Related]
6. [Langerhans cell histiocytosis: a clinicopathologic and immunohistochemical analysis of 258 cases].
Xu X; Liu WP; Yang QP; Wang WY; Liao DY; Zhao S; Bi CF; Lin L; Min M
Zhonghua Bing Li Xue Za Zhi; 2012 Feb; 41(2):91-6. PubMed ID: 22455884
[TBL] [Abstract][Full Text] [Related]
7. Rationale for the application of RANKL inhibition in the treatment of Langerhans cell histiocytosis.
Makras P; Salagianni M; Revelos K; Anastasilakis AD; Schini M; Tsoli M; Kaltsas G; Andreakos E
J Clin Endocrinol Metab; 2015 Feb; 100(2):E282-6. PubMed ID: 25375981
[TBL] [Abstract][Full Text] [Related]
8. Bone marrow involvement of Langerhans cell histiocytosis: immunohistochemical evaluation of bone marrow for CD1a, Langerin, and S100 expression.
Kim HK; Park CJ; Jang S; Cho YU; Park SH; Koh KN; Im HJ; Seo JJ
Histopathology; 2014 Dec; 65(6):742-8. PubMed ID: 25138018
[TBL] [Abstract][Full Text] [Related]
9. Expression of cellular adhesion molecules in Langerhans cell histiocytosis and normal Langerhans cells.
de Graaf JH; Tamminga RY; Kamps WA; Timens W
Am J Pathol; 1995 Oct; 147(4):1161-71. PubMed ID: 7573361
[TBL] [Abstract][Full Text] [Related]
10. Langerhans' cell histiocytosis cells are activated Langerhans' cells.
Emile JF; Fraitag S; Leborgne M; de Prost Y; Brousse N
J Pathol; 1994 Oct; 174(2):71-6. PubMed ID: 7965409
[TBL] [Abstract][Full Text] [Related]
11. Immunohistochemical analysis of langerin in langerhans cell histiocytosis and pulmonary inflammatory and infectious diseases.
Sholl LM; Hornick JL; Pinkus JL; Pinkus GS; Padera RF
Am J Surg Pathol; 2007 Jun; 31(6):947-52. PubMed ID: 17527085
[TBL] [Abstract][Full Text] [Related]
12. Langerhans cell histiocytosis of an intra-mammary lymph node in an 18-year-old woman.
Ungari M; Ferrero G; Varotti E; Gusolfino MD; Manotti L; Tanzi G; Trombatore M; Bertoni R
Pathologica; 2020 Mar; 112(1):50-55. PubMed ID: 32202540
[TBL] [Abstract][Full Text] [Related]
13. CSF1R Is Required for Differentiation and Migration of Langerhans Cells and Langerhans Cell Histiocytosis.
Lonardi S; Scutera S; Licini S; Lorenzi L; Cesinaro AM; Gatta LB; Castagnoli C; Bollero D; Sparti R; Tomaselli M; Medicina D; Calzetti F; Cassatella MA; Facchetti F; Musso T; Vermi W
Cancer Immunol Res; 2020 Jun; 8(6):829-841. PubMed ID: 32238382
[TBL] [Abstract][Full Text] [Related]
14. Langerhans' cell histiocytosis (histiocytosis X): immunophenotype and growth fraction.
Hage C; Willman CL; Favara BE; Isaacson PG
Hum Pathol; 1993 Aug; 24(8):840-5. PubMed ID: 7690735
[TBL] [Abstract][Full Text] [Related]
15. Utility of Cyclin D1 Immunostaining in Cutaneous Xanthogranuloma.
Sharma A; McAfee J; Wang L; Cook E; Ababneh E; Bergfeld WF
Am J Dermatopathol; 2021 Dec; 43(12):e141-e145. PubMed ID: 34797805
[TBL] [Abstract][Full Text] [Related]
16. Immunohistochemical expression of Langerin in Langerhans cell histiocytosis and non-Langerhans cell histiocytic disorders.
Lau SK; Chu PG; Weiss LM
Am J Surg Pathol; 2008 Apr; 32(4):615-9. PubMed ID: 18277880
[TBL] [Abstract][Full Text] [Related]
17. Fine Needle Aspiration of Langerhans Cell Histiocytosis: A Cytopathologic Study of 37 Cases.
Hang JF; Siddiqui MT; Ali SZ
Acta Cytol; 2017; 61(2):96-102. PubMed ID: 28407623
[TBL] [Abstract][Full Text] [Related]
18. Langerhans cell histiocytosis immunohistochemical expression of fascin, a dendritic cell marker.
Pinkus GS; Lones MA; Matsumura F; Yamashiro S; Said JW; Pinkus JL
Am J Clin Pathol; 2002 Sep; 118(3):335-43. PubMed ID: 12219775
[TBL] [Abstract][Full Text] [Related]
19. Immunohistochemical characterization of immune cell infiltration in paediatric and adult Langerhans cell histiocytosis.
Paredes SEY; Almeida LY; Trevisan GL; Polanco XBJ; Silveira HA; Vilela Silva E; Segato RAB; da Silva LAB; Chahud F; León JE
Scand J Immunol; 2020 Dec; 92(6):e12950. PubMed ID: 32738155
[TBL] [Abstract][Full Text] [Related]
20. No genomic aberrations in Langerhans cell histiocytosis as assessed by diverse molecular technologies.
da Costa CE; Szuhai K; van Eijk R; Hoogeboom M; Sciot R; Mertens F; Björgvinsdóttir H; Debiec-Rychter M; de Krijger RR; Hogendoorn PC; Egeler RM; Annels NE
Genes Chromosomes Cancer; 2009 Mar; 48(3):239-49. PubMed ID: 19051326
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
